123330 — Genic Co Share Price
0.000.00%
Last trade - 00:00- KR₩180bn
- KR₩185bn
- KR₩50bn
- 39
- 19
- 92
- 49
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 6.46 | ||
| PEG Ratio (f) | 0.13 | ||
| EPS Growth (f) | 105.33% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.23 | ||
| Price to Tang. Book | 8.23 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.65 | ||
| EV to EBITDA | 24.41 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 26.33% | ||
| Return on Equity | 44.9% | ||
| Operating Margin | 12.07% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 42,131.84 | 38,408.41 | 31,448.83 | 28,069.77 | 49,908.32 | 126,700 | 154,000 | 2.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +219.26 | +28.74 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Genic Co Ltd is a Korea-based company primarily engaged in the manufacturing and sales of cosmetics. The company primarily researches and develops, manufactures, and sells hydrogel mask packs based on its global patented hydrogel patent. The company’s products include gel masks, essence masks, gel eye patches, self-heating masks, cleansers, foundation and other skin care products, and makeup products. The Company distributes its products within domestic market and to overseas markets.
Directors
- Nam Huh CEO (58)
- Jong Cheol Kim OTH (43)
- Jeong Hwa Han OTH (58)
- Yeong Tae Shin OTH (61)
- Seong Eun Kim DRC (38)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 27th, 2001
- Public Since
- August 3rd, 2011
- No. of Shareholders
- 5,542
- No. of Employees
- 179
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 7,824,686
- Address
- 34, Pangyo-ro 255beon-gil, Bundang-gu, SEONGNAM, 13486
- Web
- http://www.genic21.com
- Phone
- +82 317255600
- Auditors
- Ernst & Young Han Young
Upcoming Events for 123330
Q2 2025 Genic Co Ltd Earnings Release
Similar to 123330
Ark Solutions
Korea Exchange - KOSDAQ
Barunson Co
Korea Exchange - KOSDAQ
Bbia Co
Korea Exchange - KOSDAQ
BeautySkin Co
Korea Exchange - KOSDAQ
Bonne Co
Korea Exchange - KOSDAQ
FAQ
What is the Genic Co share price?
As of Today at 20:47 UTC, shares in Genic Co are trading at KR₩23,300. This share price information is delayed by 15 minutes.
How has the Genic Co share price performed this year?
Shares in Genic Co last closed at KR₩23,300 and the price had moved by +613.41% over the past 365 days. In terms of relative price strength the Genic Co share price has outperformed the FTSE Developed Asia Pacific Index by +621.55% over the past year.
What are the analyst and broker recommendations for Genic Co?
The overall consensus recommendation for Genic Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Genic Co dividend yield?
Genic Co does not currently pay a dividend.
Does Genic Co pay a dividend?
Genic Co does not currently pay a dividend.
When does Genic Co next pay dividends?
Genic Co does not currently pay a dividend.
How do I buy Genic Co shares?
To buy shares in Genic Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Genic Co?
As of the previous close price of KR₩23,300, shares in Genic Co had a market capitalisation of KR₩180bn.
Where are Genic Co shares listed?
Here are the trading details for Genic Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 123330
What kind of share is Genic Co?
Based on an overall assessment of its quality, value and momentum Genic Co is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Genic Co share price forecast for 2025?
The analyst consensus target price for shares in Genic Co is KR₩35,457. That is 52.17% above the last closing price of KR₩23,300.
Analysts covering Genic Co currently have a consensus Earnings Per Share (EPS) forecast of KR₩3,306 for the next financial year.
Find out moreWhat is the trend in the Genic Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genic Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +11%.
As of the last closing price of KR₩23,300, shares in Genic Co were trading +38.28% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Genic Co PE Ratio?
The Genic Co PE ratio based on its reported earnings over the past 12 months is 6.46. The shares last closed at KR₩23,300.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Genic Co?
Genic Co's management team is headed by:
- Nam Huh - CEO
- Jong Cheol Kim - OTH
- Jeong Hwa Han - OTH
- Yeong Tae Shin - OTH
- Seong Eun Kim - DRC